home.aspx

 
. home.aspx home.aspx

ARCHIVED NEWS


    ZIKA MICROCEPHALY RISK LINKED TO MOTHERS ANTIBODIES

    Aug 14, 2019

    For pregnant women, Zika virus infections are incredibly worrisome due to the virus ability to cause a wide range of fetal abnormalities, with microcephaly occurring in around 5 Percent of live births by Zika-infected mothers. But, the underlying cause of the congenital abnormalities has remained un...


    READ MORE

    /news-article.aspx?ID=34553455

    POTENTIAL NEW DRUG TARGETS IDED FOR DEADLY VIRUSES

    Aug 14, 2019

    New research from investigators at Cornell University not only uncovered how two highly lethal viruses have greater pathogenic potential when their proteins are combined but may have also stumbled upon potential novel targets to combat these diseases. The Cornell team was studying how the Nipah and ...


    READ MORE

    /news-article.aspx?ID=34563456

    REGENERONS PRALUENT SIDEKICK MOVES THE NEEDLE ON BAD CHOLESTEROL

    Aug 14, 2019

    Patients with high cholesterol stemming from a rare genetic disorder struggle to keep their cholesterol levels under control despite taking lipid-busting drugs such as statins and PCSK9 inhibitors. But a new drug from Regeneron may change that the company unveiled new dataWednesday showing its lates...


    READ MORE

    /news-article.aspx?ID=34573457

    XONTOGENYS LANDOS BIOPHARMA REELS IN 60M DOLLARS TO RAMP UP IBD PROGRAM

    Aug 13, 2019

    Two years ago, Landos Biopharma was the first biotech to come out of Xontogeny, the accelerator started by former Sarepta Therapeutics chief Chris Garabedian. Now, the autoimmune specialist has picked up 60 million dollars to propel its lead program into phase 2 for inflammatory bowel disease IBD.&n...


    READ MORE

    /news-article.aspx?ID=34493449

    3D MODEL OF ALZHEIMERS SHOWS ROLL OF BLOOD-BRAIN BARRIER IN DISEASE PROGRESSION

    Aug 13, 2019

    MIT engineers have developed a tissue model that mimics beta-amyloids effects on the blood-brain barrier. Beta-amyloid plaques the protein aggregates that form in the brains of Alzheimers patients disrupt many brain functions and can kill neurons. They can also damage the blood-brain barrier BBB, th...


    READ MORE

    /news-article.aspx?ID=34503450

    BACTERIAL COLONIES ENGINEERED TO MIMIC ANOTHER ASPECT OF MULTICELLULAR LIFEFORMS

    Aug 13, 2019

    Although bacteria may form colonies and biofilms, they do not constitute multicellular lifeforms like, well, us. Bacteria lack the ability to coordinate the basics of multicellularity, which include intercellular communication, cell adhesion, and asymmetric cell division. If this ability could be en...


    READ MORE

    /news-article.aspx?ID=34513451

    BIGTINCAN RECOGNIZED BY KEY INDUSTRY ORGANIZATIONS AS LEADER IN SALES ENABLEMENT

    Aug 13, 2019

    Bigtincan (ASX:BTH), the leader in mobile, AI-powered sales enablement automation, was presented with the MarTech Breakthrough Award for “Best Sales Enablement Software for SMBs” for the second year in a row. Additionally Bigtincan was recently named a “Sales Automation Solution&rd...

    SOURCE
    READ MORE

    /news-article.aspx?ID=35133513

    STEM CELLS MIGHT BE HEADING SOON TO DENTAL OFFICES FOR TOOTH REPAIR

    Aug 12, 2019

    An international team of scientists, including researchers from the Biotechnology Center of the TU Dresden BIOTEC, says it has found a new mechanism that could offer a potential solution to tooth repair. They discovered a new population of mesenchymal stromal cells in a continuously growing mouse in...


    READ MORE

    /news-article.aspx?ID=34463446

TRENDING NEWS


    BIOENGINEERING ORGAN-SPECIFIC TISSUES WITH HIGH CELLULAR DENSITY AND EMBEDDED VASCULAR CHANNELS

    Sep 17, 2019

    Bioengineers study the development of organ-specific tissues in the lab for therapeutic applications. However, the process is highly challenging, since it requires the fabrication and maintenance of dense cellular constructs composed of approximately 108 cell/mL. Research teams have used organ build...


    READ MORE

    /news-article.aspx?ID=35273527

    PROS AND CONS OF GENETIC SCISSORS

    Sep 17, 2019

    Crispr technology has greatly facilitated gene editing. Associate Professor Thorsten Müller from Ruhr-Universität Bochum and Dr. Hassan Bukhari from Harvard Medical School discuss its pros and cons in a review article in the journal Trends in Cell Biology. They believe Crispr technology ha...


    READ MORE

    /news-article.aspx?ID=35283528

    EUROPEAN BIOTECHS SHOWCASE MULTIPLE SCLEROSIS TREATMENTS IN STOCKHOLM

    Sep 17, 2019

    Genmab, GeNeuro and other companies presented their latest data on next-generation treatments for multiple sclerosis at a conference in Stockholm. The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) gathered experts and companies working on multiple sclerosis in Sweden ...


    READ MORE

    /news-article.aspx?ID=35293529

    RESEARCHERS IDENTIFY CTLA-4 RESPONSE MARKER

    Sep 16, 2019

    The research team headed by Simon Heideger and Hendrick Poeck from Technical University of Munich together with colleagues from Memorial Sloan Kettering Cancer Center, New York, provided new evidence that activation of the RNA-sensing molecule RIG-I on tumour cells  is critical for responsivene...


    READ MORE

    /news-article.aspx?ID=35243524

    RESEARCHERS FIND NEW WAY TO FIND ANTIBIOTICS IN DIRT

    Sep 16, 2019

    Researchers at McMaster have designed a new way to rapidly identify antibiotics hidden in common dirt. Their method, published today in Nature Biotechnology, may help guide drug discovery by allowing researchers to reassess the potential of bacteria that have already been mined for rare or new compo...


    READ MORE

    /news-article.aspx?ID=35253525

    HARNESSING TOMATO JUMPING GENES COULD HELP SPEED-BREED DROUGHT-RESISTANT CROPS

    Sep 16, 2019

    Researchers from the University of Cambridge's Sainsbury Laboratory (SLCU) and Department of Plant Sciences have discovered that drought stress triggers the activity of a family of jumping genes (Rider retrotransposons) previously known to contribute to fruit shape and colour in tomatoes. Their ...


    READ MORE

    /news-article.aspx?ID=35263526

    AMGEN SHARES HIT AFTER ANALYSTS EXPOSE BURIED FDA TRIAL HALT

    Sep 13, 2019

    Thursday, Amgen posted what appeared to be a fairly innocuous update about its drug Kyprolis and other pipeline assets, but a deeper read turned up a nasty surprise.  About midway through its release, the U.S. biopharma revealed matter-of-factly that a phase 1 dose escalation clinical trial for...


    READ MORE

    /news-article.aspx?ID=35213521

    RITTER'S MICROBIOME MODULATOR FAILS LACTOSE INTOLERANCE PHASE 3

    Sep 13, 2019

    A phase 3 trial of Ritter Pharmaceuticals’ lactose intolerance prospect RP-G28 has missed its primary endpoint. The oligosaccharide microbiome modulator was no better than placebo at reducing lactose intolerance symptoms, leaving Ritter considering whether to look for strategic alternatives. R...


    READ MORE

    /news-article.aspx?ID=35223522

    CANCER DRUGS DON'T WORK THE WAY WE THOUGHT

    Sep 13, 2019

    New research recently published in the journal Science Translational Medicine surprises the oncological community with findings that a protein previously thought to influence cancer growth actually has no impact on cancer cells at all. The research was conducted by scientists at Cold Spring Harbor L...


    READ MORE

    /news-article.aspx?ID=35233523

    FRENCH BIOTECH TO DEVELOP SEPTIC SHOCK THERAPY WITH €39M SERIES B

    Sep 12, 2019

    The French company Inotrem has raised €39M to fund an immunotherapy for septic shock, an often deadly condition caused by infections in the bloodstream. Led by the Hong Kong investor Morningside Ventures, the Series B round will finance a phase IIb trial of Inotrem’s lead candidate drug n...


    READ MORE

    /news-article.aspx?ID=35183518

    RESEARCHERS GROW CITRUS DISEASE BACTERIA IN THE LAB

    Sep 12, 2019

    Washington State University researchers have for the first time grown the bacteria in a laboratory that causes Citrus Greening Disease, considered the world's most harmful citrus disease. Being able to grow the elusive and poorly understood bacterium, Candidatus Liberibacter asiaticus (CLas), wi...


    READ MORE

    /news-article.aspx?ID=35193519

    ALZHEIMER’S MEMORY LOSS COULD BE TREATED WITH CALCIUM CHANNEL BLOCKER

    Sep 12, 2019

    A little extra calcium is a good thing, to help maintain healthy bones and muscles. However, too much calcium in your neurons could be an underlying cause of memory loss for those afflicted with Alzheimer’s disease (AD). Alzheimer’s is the most common cause of dementia, but the changes i...


    READ MORE

    /news-article.aspx?ID=35203520

SPOTLIGHT

A group is defined as comprising of no more than three people from the same school and the same age grouping. If a group is made up of students in different years, these students should be entered into the oldest member’s group i.e. If a student in 4th year/Year 12 partners up with a student i

RESOURCES

Events